MYP_028535
Basic Information
Unnamed
Anticancer
Immunology Immune modulation Immunomodulatory activity
Immunology Immunomodulation Immunogenic
Standard
10 amino acids
C54H90N10O13
Standard
Sequence
LLFGLALIEV
Physicochemical Analysis
1087.35 Da
4.05
-1.24
-1.44
-0.1237
2.46
0.08
0.82
52.94
234.00
0.1000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
362.52
1.41
12.0
12.0
35.0
77.0
1.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0312023 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
melanoma; HLA-A*02:01
Cytotoxicity
RECORD: Rec_0373035 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
melanoma; HLA-A*02:01
0.0072 μM
Predicted HLA-I binding
RECORD: Rec_0377019 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Immunomodulatory
RECORD: Rec_0399888 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
melanoma; HLA-A*02:01
TCR analysis
RECORD: Rec_0417790 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
melanoma; HLA-A*02:01
CTL stimulation